Trials / Completed
CompletedNCT01125657
A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-B
Pharmacokinetic Study of YM150 - The Verification ot the Bioequivalence Between YM150 Formulation-A and YM150 Formulation-B -
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
This study is to compare its pharmacokinetics profile of two YM150 formulations by 2x2 crossover method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM150 | oral |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2010-05-18
- Last updated
- 2010-05-25
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01125657. Inclusion in this directory is not an endorsement.